A DOUBLE-BLIND-STUDY TO COMPARE THE EFFICACY, TOLERANCE AND SAFETY OF 2 DOSES OF THE ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR RAMIPRIL WITH PLACEBO

被引：16

作者：

VILLAMIL, AS

CAIRNS, V

WITTE, PU

BERTOLASI, CA

机构：

[1] HOECHST AG,ATOM & SOLID STATE PHYS,POSTFACH 800320,D-6230 FRANKFURT 80,FED REP GER

[2] HOSP GRAL AGUDOS,DEPT CARDIOL,BUENOS AIRES,ARGENTINA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1987年 / 59卷 / 10期

关键词：

D O I：

10.1016/0002-9149(87)90064-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：D110 / D114

页数：5

共 11 条

[1]

BECKER RHA, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1411

[2] PRELIMINARY EXPERIENCES WITH HOE 498, A NOVEL LONG-ACTING CONVERTING-ENZYME-INHIBITOR, IN HYPERTENSIVE PATIENTS [J].

DELEEUW, PW ;

LUGTENBURG, PL ;

VANHOUTEN, H ;

LOOMAN, JHM ;

BIRKEHAGER, WH .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (06) :1161-1165

[3]

FELDER K, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1452

[4]

METZGER H, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1402

[5]

SCHOLKENS BA, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1417

[6] EFFECTS OF THE NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, RAMIPRIL, IN PATIENTS WITH ESSENTIAL-HYPERTENSION [J].

STUMPE, KO ;

OVERLACK, A ;

KOLLOCH, R ;

SCHATZ, J ;

WITTE, PU ;

PAHNKE, K .

KLINISCHE WOCHENSCHRIFT, 1986, 64 (12) :558-562

[7]

VIDT DG, 1984, J HYPERTENSION S2, V2, P81

[8]

WITTE PU, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1448

[9] PHARMACOKINETICS AND PHARMACODYNAMICS OF A NOVEL ORALLY ACTIVE ANGIOTENSIN CONVERTING ENZYME-INHIBITOR (HOE 498) IN HEALTHY-SUBJECTS [J].

WITTE, PU ;

IRMISCH, R ;

HAJDU, P ;

METZGER, H .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 27 (05) :577-581

[10]

WITTE PU, 1983, IRCS MED SCI-BIOCHEM, V11, P1053

← 1 2 →